Lindbrook Capital »

Cg Oncology shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.2k 48 24.50

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Apple Stock (AAPL)
Golub Cap Bdc Cef (GBDC)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Amazon.com Stock (AMZN)
Ishares Russell 1000 Value Etf Etf (IWD)
Powershares Qqq Tr Etf (QQQ)
Broadcom Stock (AVGO)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Google Stock (GOOGL)

View all positions for Lindbrook Capital

Top funds holding Cg Oncology

Vanguard Group
Decheng Capital
Wellington Management Company
BlackRock
FMR
TCG Crossover Management
Braidwell
Foresite Capital Management VI
Alliancebernstein
UBS Group
State Street Corporation
Kynam Capital Management
OrbiMed Advisors
Rtw Investments
Avidity Partners Management

View all funds holding Cg Oncology